Gainers
- Ardelyx, Inc. ARDX shares rose 71.2% to close at $5.82 on Tuesday after the company's pivotal phase 3 AMPLIFY study of tenapanor in combination with phosphate binders in patients with chronic kidney disease met primary and all key secondary endpoints.
- Cidara Therapeutics, Inc. CDTX shares jumped 39.9% to close at $2.35 on Tuesday after the company announced it has formed a partnership with Mundipharma to develop and commercialize Rezafungin. Cidara will receive an upfront payment of $30 million and an equity investment of $9 million.
- Net Element, Inc. NETE shares jumped 25.9% to close at $6.03 on Tuesday.
- Conn's, Inc. CONN gained 18.3% to close at $23.85 as the company reported better-than-expected Q2 earnings.
- Tilray, Inc. TLRY climbed 17.3% to close at $30.10 following vague, questionable chatter indicating a 'major tobacco player' is planning to make a bid for the company.
- Endeavour Silver Corp. EXK shares rose 15.5% to close at $3.05.
- MAM Software Group, Inc. MAMS rose 15.2% to close at $12.04 after the company announced it has agreed to be acquired by Kerridge Commercial Systems for $12.12 per share in cash.
- Kadmon Holdings, Inc. KDMN gained 15% to close at $2.46.
- Reven Housing REIT, Inc. RVEN rose 14.7% to close at $5.05.
- Emergent BioSolutions Inc. EBS gained 14.5% to close at $50.14 after the company was awarded a 10-year HHS contract to deliver ACAM2000 smallpox vaccine to the U.S. Strategic National Stockpile.
- Alexco Resource Corp. AXU gained 14.7% to close at $2.73.
- Afya Limited AFYA rose 13.5% to close at $24.85 after the company issued 2H guidance.
- SeaChange International, Inc. SEAC climbed 12.9% to close at $2.62.
- InMode Ltd. INMD shares rose 12.5% to close at $22.39.
- Hebron Technology Co., Ltd. HEBT gained 11.6% to close at $3.55.
- InspireMD, Inc. NSPR shares rose 10.8% to close at $2.36.
- Zealand Pharma A/S ZEAL gained 10.6% to close at $21.23. Boehringer Ingelheim and Zealand Pharma announced plans to initiate Phase 2 development of the GLP-1/glucagon dual agonist BI 456906.
- Dynavax Technologies Corporation DVAX gained 10.6% to close at $4.58.
- The Medicines Company MDCO rose 10.4% to close at $46.31 after the company presented results from its ORION-11 trial at ESC Congress 2019. In the trial, inclisiran met all primary and secondary efficacy endpoints.
- Edison Nation, Inc. EDNT gained 9.3% to close at $2.46.
- Concert Pharmaceuticals, Inc. CNCE rose 9.3% to close at $11.01.
- Protagonist Therapeutics, Inc. PTGX shares jumped 9.3% to close at $14.24.
- Insulet Corporation PODD shares surged 8.9% to close at $167.95.
- Owens & Minor, Inc. OMI rose 8.8% to close at $5.53.
- RedHill Biopharma Ltd. RDHL gained 7.6% to close at $8.22 on Tuesday.
- Organogenesis Holdings Inc. ORGO shares gained 7.5% to close at $4.43.
Losers
- Navios Maritime Holdings Inc. NM shares tumbled 24.5% to close at $4.77 on Tuesday.
- Napco Security Technologies, Inc. NSSC shares fell 21.9% to close at $26.94 on Tuesday after the company reported Q4 results.
- Mirum Pharmaceuticals, Inc. MIRM shares dipped 20.7% to close at $10.06.
- Liquidia Technologies, Inc. LQDA dropped 19% to close at $3.29.
- Vapotherm, Inc. VAPO shares declined 18.1% to close at $9.50 on Tuesday.
- Neoleukin Therapeutics, Inc. NLTX fell 16.2% to close at $2.80.
- NF Energy Saving Corporation BIMI fell 15.8% to close at $1.81.
- California Resources Corporation CRC tumbled 15.3% to close at $8.29.
- PhaseBio Pharmaceuticals, Inc. PHAS fell 14.6% to close at $7.38.
- Cleveland-Cliffs Inc. CLF shares dropped 14.6% to close at $6.78.
- Unit Corporation UNT shares declined 13.5% to close at $2.62.
- Fang Holdings Limited SFUN fell 13% to close at $1.80.
- Plus Therapeutics, Inc. PSTV dropped 12.9% to close at $13.36.
- Qutoutiao Inc. QTT shares dipped 12.9% to close at $4.04.
- ShockWave Medical, Inc. SWAV fell 11.8% to close at $36.92. Shockwave received FDA Breakthrough Device Designation for the Coronary IVL System.
- Grupo Financiero Galicia S.A. GGAL dropped 11.7% to close at $9.57.
- Kezar Life Sciences, Inc. KZR shares fell 11.2% to close at $3.00.
- Fuwei Films (Holdings) Co., Ltd. FFHL declined 11.1% to close at $3.38.
- The Goldfield Corporation GV shares dropped 10.8% to close at $2.14.
- Global Cord Blood Corporation CO shares dropped 10.5% to close at $4.53.
- Atomera Incorporated ATOM shares tumbled 10.5% to close at $3.65.
- Smart Sand, Inc. SND shares fell 10.1% to close at $2.13.
- Rayonier Advanced Materials Inc. RYAM dropped 10% to close at $3.16.
- Jumia Technologies AG JMIA shares fell 9.9% to close at $10.05.
- ZAGG Inc ZAGG dropped 9.8% to close at $5.78.
- Evolent Health, Inc. EVH declined 9.6% to close at $6.21.
- Signet Jewelers Limited SIG fell 9.5% to close at $11.08.
- OpGen, Inc. OPGN dipped 9.4% to close at $6.52.
- ProPetro Holding Corp. PUMP dropped 9.2% to close at $9.67 after Piper Jaffray downgraded the stock from Overweight to Neutral and lowered the price target from $32.5 to $17.
- Sasol Limited SSL dropped 8.7% to close at $17.27.
- Pintec Technology Holdings Limited PT shares fell 8% to close at $2.87 after entering into a loan agreement with Shanghai Mantu Technology Co. Ltd.
- Nine Energy Service, Inc. NINE shares fell 7.7% to close at $5.06.
- Aridis Pharmaceuticals, Inc. ARDS fell 7.5% to close at $10.80 on Tuesday. Aridis announced ahead of the market open that its first-in patient Phase 2 study that evaluated its AR-105 did not meet theprimary endpoint of demonstrating superiority in clinical cure rates on Day 21 compared to placebo. The drug is a fully human IgG1 monoclonal antibody for ventilator-associated pneumonia, or VAP, caused by gram-negative Pseudomonas aeruginosa. Additionally, the company said it noted a statistically significant imbalance in all-cause mortality, as well as serious adverse event, or SAE, rates between the treatment groups that favored placebo. Aridis said it will no longer allocate further resources for the clinical development of AR-105.
- Intelsat S.A. I fell 6.2% to close at $19.39 after Eutelsat withdrew from the C-Band Alliance with Intelsat and SES.
- Barnes & Noble Education, Inc. BNED fell 6.2% to close at $3.66.
- MoSys, Inc. MOSY fell 5.6% to close at $2.51 after rising 5.56% on Friday.
- BioLineRx Ltd. BLRX fell 4.9% to close at $2.71. BioLineRx disclosed that it has successfully completed dose-escalation part of Phase 1/2a clinical study for AGI-134 immunotherapy for the treatment of solid tumors.
- Seadrill Limited SDRL fell 4.7% to close at $2.24 on Tuesday after dropping 6.75% on Friday.
- Mattel, Inc. MAT dropped 4.6% to close at $9.35 after some of the 15% tariffs on $112 billion worth of Chinese goods went into effect on Sunday.
- Tata Motors Limited TTM dropped 4.6% to close at $7.84 in sympathy with the overall Indian market. The Sensex suffered its biggest fall this year potentially over concerns of economic growth slowing.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralConsumer DiscretionaryLeisure ProductsMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in